StonvexLoading…
StonvexCore line items from EVI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q1 2025 2025-03-31 | Q4 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $324.70M | $223.56M | $279.87M | $186.34M |
Operating Income | $10.07M | $7.81M | $9.65M | $7.38M |
Net Income | $4.97M | $4.22M | $5.40M | $4.36M |
EPS (Diluted) | $0.31 | $0.26 | $0.35 | $0.29 |
Total Assets | $318.23M | $315.63M | $251.79M | $248.80M |
Total Liabilities | $172.23M | $171.66M | $111.58M | $110.79M |
Cash & Equivalents | $4.32M | $4.25M | $5.91M | $3.90M |
Free Cash Flow OCF − CapEx | $1.98M | $1.44M | $8.16M | $52.00K |
Shares Outstanding | 13.65M | 13.67M | 13.14M | 13.12M |